Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Charles Dauriac"'
Autor:
Mehdi Khellaf, Jean-François Viallard, Mohamed Hamidou, Stéphane Cheze, Françoise Roudot-Thoraval, François Lefrere, Olivier Fain, Sylvain Audia, Jean-François Abgrall, Jean-Marie Michot, Charles Dauriac, Sophie Lefort, Emmanuel Gyan, Mathilde Niault, Jean-Marc Durand, Laetitia Languille, David Boutboul, Philippe Bierling, Marc Michel, Bertrand Godeau
Publikováno v:
Haematologica, Vol 98, Iss 6 (2013)
Romiplostim and eltrombopag, the first thrombopoietic receptor-agonists with demonstrated efficacy against immune thrombocytopenia in prospective controlled studies, were recently authorized in most countries for adults with chronic immune thrombocyt
Externí odkaz:
https://doaj.org/article/d05cfc94e47d4e3fa3395e2c05f14085
Autor:
Yves Beguin, Elodie Drumez, Mauricette Michallet, Bruno Lioure, Jordan Gauthier, Martin Carre, Stephane Vigouroux, Didier Blaise, Ibrahim Yakoub-Agha, Patrice Chevallier, Felipe Suarez, Anne Huynh, Charles Dauriac, Marie Robin, Jacques-Olivier Bay, Pierre-Simon Rohrlich, Jérôme Cornillon, Jean-Henri Bourhis, Alexis Caulier, Federico Garnier, Régis Peffault de Latour, Yohan Desbrosses, Alain Duhamel, Stéphanie Nguyen
Publikováno v:
Current Research in Translational Medicine
Current Research in Translational Medicine, Elsevier-Masson SAS, 2019, 67 (1), pp.8-15
Current Research in Translational Medicine, 2019, 67 (1), pp.8-15
Current Research in Translational Medicine, Elsevier-Masson SAS, 2019, 67 (1), pp.8-15
Current Research in Translational Medicine, 2019, 67 (1), pp.8-15
Purpose We developed a prognostic scoring system to evaluate the prognosis of myelodysplastic syndrome (MDS) patients surviving more than 100 days allogeneic hematopoietic cell transplantation after (allo-HCT). Patients and methods We performed a lan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af79d36722d3f5351af8ef331aa798eb
https://hal.archives-ouvertes.fr/hal-02055904
https://hal.archives-ouvertes.fr/hal-02055904
Autor:
Mauricette Michallet, Justine Decroocq, Florence Beckerich, Felipe Suarez, Yves Beguin, Yosr Hicheri, Charlotte Jubert, Laurence Clement, Raphael Itzykson, Jacques-Olivier Bay, Nathalie Dhedin, Jean-Henri Bourhis, Didier Blaise, Martin Carre, Patrice Chevallier, Mélanie Mercier, Stephane Vigouroux, Charles Dauriac, Eric Deconinck, Ibrahim Yakoub-Agha, Marie-Pierre Ledoux, Natacha Maillard, Jérôme Cornillon, Nathalie Contentin, Stephanie Nguyen-Quoc, Mohamad Mohty, Régis Peffault de Latour, Amandine Charbonnier, Anne Huynh, Nicole Raus, Gaelle Guillerm
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2018, 93 (3), pp.416-423. ⟨10.1002/ajh.25004⟩
American Journal of Hematology, Wiley, 2018, 93 (3), pp.416-423. 〈10.1002/ajh.25004〉
American Journal of Hematology, 2018, 93 (3), pp.416-423. ⟨10.1002/ajh.25004⟩
American Journal of Hematology, Wiley, 2018, 93 (3), pp.416-423. ⟨10.1002/ajh.25004⟩
American Journal of Hematology, Wiley, 2018, 93 (3), pp.416-423. 〈10.1002/ajh.25004〉
American Journal of Hematology, 2018, 93 (3), pp.416-423. ⟨10.1002/ajh.25004⟩
Patients with acute myeloid leukemia (AML) in relapse or refractory to induction therapy have a dismal prognosis. Allogeneic hematopoietic stem cell transplantation is the only curative option. In these patients, we aimed to compare the results of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e80a22e02f1d53298ac034ea38a5e28
https://hal.archives-ouvertes.fr/hal-01712412
https://hal.archives-ouvertes.fr/hal-01712412
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mauricette Michallet, Faezeh Legrand, Natacha Maillard, Jérôme Cornillon, Patrice Chevallier, Gérard Socié, Jacques-Olivier Bay, Bernard Rio, Noel Milpied, Sébastien Maury, Tabassome Simon, Sabine Furst, Sylvie Chevret, Karin Bilger, Agnes Buzyn, Laurence Clement, Eliane Gluckman, Stephane Vigouroux, Anne Huynh, Ibrahim Yakoub-Agha, Anne Sirvent, Sylvie Françoise, Vanderson Rocha, Patrice Ceballos, Annalisa Ruggeri, Claude Eric Bulabois, Madalina Uzunov, Stéphanie Nguyen, Geneviève Margueritte, Gérard Michel, Charles Dauriac
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(3):445-453
A prospective phase II multicenter trial was performed with the aim to obtain less than 25% nonrelapse mortality (NRM) after unrelated cord blood transplantation (UCBT) for adults with acute myeloid leukemia (AML) using a reduced-intensity conditioni
Autor:
S. Vigouroux, L Souchet, Patrice Chevallier, Anne Sirvent, C-E. Bulabois, Faezeh Legrand, Laurence Clement, Jérôme Cornillon, S. Furst, Sébastien Maury, Vivien Béziat, J Lejeune, Bernard Rio, Sylvie Chevret, G Margueritte, Sylvie François, Karin Bilger, Vincent Vieillard, G. Michel, Madalina Uzunov, Gérard Socié, Marie-Cécile Michallet, Patrice Ceballos, V. Rocha, J.-O. Bay, N. Maillard, Charles Dauriac, I. Yakoub-Agha, Abla Achour, Anne Huynh, Stéphanie Nguyen
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2017, 52 (10), pp.1428-1435. ⟨10.1038/bmt.2017.122⟩
Bone Marrow Transplantation, 2017, 52 (10), pp.1428-1435. ⟨10.1038/bmt.2017.122⟩
Bone Marrow Transplantation, Nature Publishing Group, 2017, 52 (10), pp.1428-1435. ⟨10.1038/bmt.2017.122⟩
Bone Marrow Transplantation, 2017, 52 (10), pp.1428-1435. ⟨10.1038/bmt.2017.122⟩
Unrelated cord blood transplantation (UCBT) after a reduced intensity conditioning regimen (RIC) has extended the use of UCB in elderly patients and those with co-morbidities without an HLA-identical donor, although post-transplant relapse remains a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5a33a764871c5a2a40a4c88942ee22b
https://hal.archives-ouvertes.fr/hal-01655980
https://hal.archives-ouvertes.fr/hal-01655980
Autor:
Jean El Cheikh, Ibrahim Yakoub-Agha, Laurence Clement, Alain Duhamel, Sylvie François, Stephane Vigouroux, Patrice Chevallier, Mauricette Michallet, Charles Dauriac, Anne Huynh, Etienne Daguindau, Simona Lapusan, Marie Robin, Bruno Lioure, Patrice Ceballos, Natacha Maillard, Jérôme Cornillon, Yves Beguin, Jacques-Olivier Bay, Mohamad Mohty, Faezeh Legrand, Claude-Eric Bulabois, Remy Dulery, Gandhi Damaj, Alice Garnier, Gaelle Guillerm
Publikováno v:
Biology of Blood and Marrow Transplantation. 20:646-654
We investigated the impact of rabbit antithymocyte globulins (ATG) on patient outcomes after allogeneic stem cell transplantation (allo-SCT) for progressive myelodysplastic syndrome (MDS). Of the 242 consecutive patients who underwent allo-SCT for pr
Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT
Autor:
Salut Brunet, Alois Gratwohl, Zwaan Fe, Mauricette Michallet, Witz F, Bourdeau He, L. Molina, Corront B, Moine A, Charles Dauriac, J P Jouet, J Soler, William Arcese, Noel-Jean Milpied
Publikováno v:
Leukemialymphoma. 5
Allogeneic bone marrow transplantation (BMT) was performed in 17 patients with chronic lymphocytic leukemia (CLL): 15 resistant and 2 untreated forms; 12 males and 5 females with a mean age of 40 years (32-49). The conditioning regimen and graft vers
Autor:
Hervé Avet-Loiseau, Sylvain Choquet, Murielle Roussel, Marie Lorraine Chretien, Annie Brion, Bertrand Arnulf, Lotfi Benboubker, Laurent Garderet, Bruno Royer, Margaret Macro, Mourad Tiab, Carine Chaleteix, Sabine Brechignac, Charles Dauriac, Sylvie Cailleres, Philippe Moreau, Lionel Karlin, Luc-Matthieu Forneker, Marc Wetterwald, Laurent Frenzel, Thierry Facon, Karim Belhadj, Jean Pierre Marolleau, Cyrille Hulin, Stephane Minvielle, Xavier Leleu, Momar Diouf, Jean Gabriel Fuzibet
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2016, 34 (18), pp.2125-2132. ⟨10.1200/JCO.2015.63.1929⟩
Journal of Clinical Oncology, 2016, 34 (18), pp.2125-2132. ⟨10.1200/JCO.2015.63.1929⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2016, 34 (18), pp.2125-2132. ⟨10.1200/JCO.2015.63.1929⟩
Journal of Clinical Oncology, 2016, 34 (18), pp.2125-2132. ⟨10.1200/JCO.2015.63.1929⟩
Purpose Primary plasma cell leukemia (pPCL) is a rare and aggressive malignancy with a poor prognosis. With conventional chemotherapy, patients typically die within 1 year. In all but one of the retrospective studies reported to date, bortezomib and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765c21d6459f434c72e5e195b3f42070
https://www.hal.inserm.fr/inserm-01822878/file/jco.2015.63.1929.pdf
https://www.hal.inserm.fr/inserm-01822878/file/jco.2015.63.1929.pdf
Autor:
Nathalie Carpentier, Franck E. Nicolini, Michel Tulliez, Charles Dauriac, Françoise Huguet, Gabriel Etienne, Pascale Cony-Makhoul, Isabelle Bourdeix, Valérie Coiteux, Agnès Guerci-Bresler, Frédéric Maloisel
Publikováno v:
British journal of haematology. 174(1)
The availability of tyrosine kinase inhibitors has extended therapeutic options for chronic myeloid leukaemia (CML) patients. Monitoring recommendations and clinical response goals have recently been updated. The objective of this study was to descri